FindTrial
Sign In

Study of biomarkers in prognosis of oral squamous cell carcinoma

Study of biomarkers in prognosis of oral squamous cell carcinoma

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300069916
Enrollment
Unknown
Registered
2023-03-29
Start date
2023-04-01
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Oral Squamous Cell Carcinoma

Interventions

high expression group:no intervention
low expression group:no intervention

Sponsors

The Affiliated Stomatology Hospital of Guizhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1)The pathological diagnosis was squamous cell carcinoma (2)No preoperative treatment was received,including:surgical treatment, radiotherapy, chemotherapy or immunotherapy

Exclusion criteria

Exclusion criteria: (1)There are tumors in other areas (2)There are serious lesions in heart, lungs, kidneys and other important organs

Design outcomes

Primary

MeasureTime frame
Expression level of UBE2L3 and CENPN;—

Countries

China

Contacts

Public ContactHelin Chen

The Affiliated Stomatology Hospital of Guizhou Medical University

helinchen0509@163.com+86 189 8516 2958

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026